A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins - PubMed (original) (raw)
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins
T D Littlewood et al. Nucleic Acids Res. 1995.
Free PMC article
Abstract
A number of proteins have been rendered functionally oestrogen-dependent by fusion with the hormone-binding domain of the oestrogen receptor. There are, however, several significant disadvantages with such fusion proteins. First, their use in cells in vitro requires phenol red-free medium and laborious stripping of steroid hormones from serum in order to avoid constitutive activation. Secondly, control of oestrogen receptor fusion proteins in vivo is precluded by high endogenous levels of circulating oestrogens. Thirdly, the hormone-binding domain of the oestrogen receptor functions as a hormone-dependent transcriptional activation domain making interpretation of fusions with transcription factors problematical. In order to overcome these drawbacks we have used a transcriptionally inactive mutant of the murine oestrogen receptor which is unable to bind oestrogen yet retains normal affinity for the synthetic ligand, 4-hydroxytamoxifen. When the hormone-binding domain of this mutant oestrogen receptor is fused to the C-terminus of the c-Myc protein, Myc-induced proliferation and apoptosis in fibroblasts becomes dependent on 4-hydroxytamoxifen, but remains refractory to 17 beta-oestradiol.
Similar articles
- Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.
Feil R, Wagner J, Metzger D, Chambon P. Feil R, et al. Biochem Biophys Res Commun. 1997 Aug 28;237(3):752-7. doi: 10.1006/bbrc.1997.7124. Biochem Biophys Res Commun. 1997. PMID: 9299439 - Interaction of proteins with transcriptionally active estrogen receptors.
Cavaillès V, Dauvois S, Danielian PS, Parker MG. Cavaillès V, et al. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10009-13. doi: 10.1073/pnas.91.21.10009. Proc Natl Acad Sci U S A. 1994. PMID: 7937828 Free PMC article. - Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine.
White R, Sjöberg M, Kalkhoven E, Parker MG. White R, et al. EMBO J. 1997 Mar 17;16(6):1427-35. doi: 10.1093/emboj/16.6.1427. EMBO J. 1997. PMID: 9135157 Free PMC article. - Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens.
Green S. Green S. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):747-51. doi: 10.1016/0960-0760(90)90415-h. J Steroid Biochem Mol Biol. 1990. PMID: 2285586 Review. - Chimeric receptors as gene switches.
Allgood VE, Eastman EM. Allgood VE, et al. Curr Opin Biotechnol. 1997 Aug;8(4):474-9. doi: 10.1016/s0958-1669(97)80071-7. Curr Opin Biotechnol. 1997. PMID: 9265728 Review.
Cited by
- A Mouse Model for Conditional Expression of Activated β-Catenin in Epidermal Keratinocytes.
Maurya VK, Ying Y, Lydon JP. Maurya VK, et al. Transgenic Res. 2024 Aug 7. doi: 10.1007/s11248-024-00402-z. Online ahead of print. Transgenic Res. 2024. PMID: 39110314 - Established and emerging techniques for the study of microglia: visualization, depletion, and fate mapping.
Bobotis BC, Halvorson T, Carrier M, Tremblay MÈ. Bobotis BC, et al. Front Cell Neurosci. 2024 Feb 15;18:1317125. doi: 10.3389/fncel.2024.1317125. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38425429 Free PMC article. Review. - Cellular senescence: Neither irreversible nor reversible.
Reimann M, Lee S, Schmitt CA. Reimann M, et al. J Exp Med. 2024 Apr 1;221(4):e20232136. doi: 10.1084/jem.20232136. Epub 2024 Feb 22. J Exp Med. 2024. PMID: 38385946 Free PMC article. - Prolonged tamoxifen-enriched diet is associated with cardiomyopathy and nutritional frailty in mice.
Halpage J, DaSilva Pantoja P, Mancarella S. Halpage J, et al. Exp Physiol. 2024 Apr;109(4):513-523. doi: 10.1113/EP091668. Epub 2024 Jan 30. Exp Physiol. 2024. PMID: 38291801 Free PMC article. - Genome-wide analysis of DNA-PK-bound MRN cleavage products supports a sequential model of DSB repair pathway choice.
Deshpande RA, Marin-Gonzalez A, Barnes HK, Woolley PR, Ha T, Paull TT. Deshpande RA, et al. Nat Commun. 2023 Sep 16;14(1):5759. doi: 10.1038/s41467-023-41544-8. Nat Commun. 2023. PMID: 37717054 Free PMC article.
References
- Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8028-32 - PubMed
- Breast Cancer Res Treat. 1987 Oct;10(1):31-5 - PubMed
- Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9252-6 - PubMed
- Mol Cell Endocrinol. 1990 Nov 12;74(1):C69-76 - PubMed
- Nature. 1989 Jul 6;340(6228):66-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases